Our leadership team has over 25 years of experience in intranasal and inhaled drug product development of a variety of device technology platforms including DPIs, Soft mist inhalers, Nebulizers, and pMDIs of small as well as biologic molecules. The team also has in-depth knowledge of solubilization technologies, particle engineering technologies, and solid-state chemistry.
Please reach out to bd@kenoxpharma.us to learn more about our expertise, capabilities, or partnering opportunities.